Cell Growth & Differentiation, Vol 4, Issue 12 1023-1031, Copyright © 1993 by American Association of Cancer Research

ARTICLES

Expression of the Wilms' tumor suppressor gene WT1 during mouse embryogenesis

RR Rackley, AM Flenniken, NP Kuriyan, PM Kessler, MH Stoler and BR Williams
Department of Cancer Biology, Cleveland Clinic Foundation, Ohio 44195-5001.

WT1 is a Wilms' tumor suppressor gene that maps to human chromosome 11p13 and encodes a putative transcription factor implicated in controlling normal urogenital development. Sporadic homozygous mutations in WT1 result in the development of Wilms' tumor (nephroblastoma), and heterozygous germline mutations can give rise to a phenotype which includes nephropathy and urogenital abnormalities (the Denys-Drash syndrome). Thus, inappropriate expression of WT1 results in developmental abnormalities affecting the urogenital system. To better define the temporal and spatial distribution of WT1 expression during embryogenesis, we have used in situ mRNA hybridization and immunohistochemistry to examine WT1 expression in murine embryos during the period prior to and throughout active organogenesis. Prior to embryological day 9.5 (E9.5), WT1 mRNA expression is absent in the embryo proper but is strongly expressed in the maternal uterus. During the initiation of organogenesis on E10.5, WT1 mRNA is localized within the pronephric and mesonephric tissues. By E11.5, the nephrogenic cord, urogenital ridge, and condensing metanephric tissue show intense WT1 hybridization signals, and increasingly centripetal expression of WT1 in the kidney correlates with renal differentiation from days E11.5 through E16.5. The stromal cell components in the developing gonad show expression of WT1 by E10.5, whereas in the remaining organs examined, WT1 expression is restricted to the uterus, spleen, abdominal wall musculature, and mesothelial lining of organs within the thoracic and abdominal cavities. Interestingly, there is also WT1 expression in the central nervous system which localizes to the ependymal layer of the ventral aspect of the spinal cord.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. Boyer, L. Hermo, M. Paquet, B. Robaire, and D. Boerboom Seminiferous Tubule Degeneration and Infertility in Mice with Sustained Activation of WNT/CTNNB1 Signaling in Sertoli Cells Biol Reprod, September 1, 2008; 79(3): 475 - 485. [Abstract] [Full Text] [PDF]

				J. Klattig, R. Sierig, D. Kruspe, B. Besenbeck, and C. Englert Wilms' Tumor Protein Wt1 Is an Activator of the Anti-Mullerian Hormone Receptor Gene Amhr2 Mol. Cell. Biol., June 15, 2007; 27(12): 4355 - 4364. [Abstract] [Full Text] [PDF]

				K. M. Kirschner, N. Wagner, K.-D. Wagner, S. Wellmann, and H. Scholz The Wilms Tumor Suppressor Wt1 Promotes Cell Adhesion through Transcriptional Activation of the {alpha}4integrin Gene J. Biol. Chem., October 20, 2006; 281(42): 31930 - 31939. [Abstract] [Full Text] [PDF]

				C. Dame, K. M. Kirschner, K. V. Bartz, T. Wallach, C. S. Hussels, and H. Scholz Wilms tumor suppressor, Wt1, is a transcriptional activator of the erythropoietin gene Blood, June 1, 2006; 107(11): 4282 - 4290. [Abstract] [Full Text] [PDF]

				A. Brendolan, E. Ferretti, V. Salsi, K. Moses, S. Quaggin, F. Blasi, M. L. Cleary, and L. Selleri A Pbx1-dependent genetic and transcriptional network regulates spleen ontogeny Development, July 1, 2005; 132(13): 3113 - 3126. [Abstract] [Full Text] [PDF]

				M. S. Orloff, S. K. Iyengar, C. A. Winkler, K. A. B. Goddard, R. A. Dart, T. S. Ahuja, M. Mokrzycki, W. A. Briggs, S. M. Korbet, P. L. Kimmel, et al. Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population Physiol Genomics, April 14, 2005; 21(2): 212 - 221. [Abstract] [Full Text] [PDF]

				N. Wagner, K.-D. Wagner, A. Hammes, K. M. Kirschner, V. P. Vidal, A. Schedl, and H. Scholz A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system Development, March 15, 2005; 132(6): 1327 - 1336. [Abstract] [Full Text] [PDF]

				J. Renshaw, R. M. Orr, M. I. Walton, R. te Poele, R. D. Williams, E. V. Wancewicz, B. P. Monia, P. Workman, and K. Pritchard-Jones Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: Antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival Mol. Cancer Ther., November 1, 2004; 3(11): 1467 - 1484. [Abstract] [Full Text] [PDF]

				M. T. Discenza and J. Pelletier Insights into the physiological role of WT1 from studies of genetically modified mice Physiol Genomics, February 13, 2004; 16(3): 287 - 300. [Abstract] [Full Text] [PDF]

				C. Tilmann and B. Capel Cellular and Molecular Pathways Regulating Mammalian Sex Determination Recent Prog. Horm. Res., January 1, 2002; 57(1): 1 - 18. [Abstract] [Full Text] [PDF]

				T. H. LEE and J. PELLETIER Functional characterization of WT1 binding sites within the human vitamin D receptor gene promoter Physiol Genomics, December 21, 2001; 7(2): 187 - 200. [Abstract] [Full Text] [PDF]

				Z. Sun and N. Hopkins vhnf1, the MODY5 and familial GCKD-associated gene, regulates regional specification of the zebrafish gut, pronephros, and hindbrain Genes & Dev., December 1, 2001; 15(23): 3217 - 3229. [Abstract] [Full Text] [PDF]

				L. Gnessi, S. Basciani, S. Mariani, M. Arizzi, G. Spera, C. Wang, C. Bondjers, L. Karlsson, and C. Betsholtz Leydig Cell Loss and Spermatogenic Arrest in Platelet-derived Growth Factor (PDGF)-A-deficient Mice J. Cell Biol., May 29, 2000; 149(5): 1019 - 1026. [Abstract] [Full Text] [PDF]

				V. Scharnhorst, P. Dekker, A. J. van der Eb, and A. G. Jochemsen Physical Interaction between Wilms Tumor 1 and p73 Proteins Modulates Their Functions J. Biol. Chem., March 31, 2000; 275(14): 10202 - 10211. [Abstract] [Full Text] [PDF]

				J. J. Tremblay and R. S. Viger Transcription Factor GATA-4 Enhances Mullerian Inhibiting Substance Gene Transcription through a Direct Interaction with the Nuclear Receptor SF-1 Mol. Endocrinol., August 1, 1999; 13(8): 1388 - 1401. [Abstract] [Full Text]

				J. Kim, D. Prawitt, N. Bardeesy, E. Torban, C. Vicaner, P. Goodyer, B. Zabel, and J. Pelletier The Wilms' Tumor Suppressor Gene (wt1) Product Regulates Dax-1 Gene Expression during Gonadal Differentiation Mol. Cell. Biol., March 1, 1999; 19(3): 2289 - 2299. [Abstract] [Full Text] [PDF]

				L. Bergmann, C. Miething, U. Maurer, J. Brieger, T. Karakas, E. Weidmann, and D. Hoelzer High Levels of Wilms' Tumor Gene (wt1) mRNA in Acute Myeloid Leukemias Are Associated With a Worse Long-Term Outcome Blood, August 1, 1997; 90(3): 1217 - 1225. [Abstract] [Full Text] [PDF]

				H. T. Cohen, S. A. Bossone, G. Zhu, G. A. McDonald, and V. P. Sukhatme Sp1 Is a Critical Regulator of the Wilms' tumor-1 Gene J. Biol. Chem., January 31, 1997; 272(5): 2901 - 2913. [Abstract] [Full Text] [PDF]

				S. Ernstsson, S. Pierrou, M. Hulander, A. Cederberg, M. Hellqvist, P. Carlsson, and S. Enerback Characterization of the Human Forkhead Gene FREAC-4. EVIDENCE FOR REGULATION BY WILMS' TUMOR SUPPRESSOR GENE (WT-1) AND p53 J. Biol. Chem., August 30, 1996; 271(35): 21094 - 21099. [Abstract] [Full Text] [PDF]